This study is an effort by the Atrium Health Carolinas Neuromuscular/ALS MDA Clinic to create a registry of ALS patients who have had the SARS-CoV-2 (COVID-19) infection. The purpose of this registry is to learn how COVID-19 affects the course of ALS and the impact, if any, of edaravone, riluzole and other ALS medications on COVID-19. Your responses will help the medical community learn how to better treat ALS patients who develop this viral infection.

Loading... Loading...
Mark field as:
[Clear value]
No information (NI)
Invalid (INV)
Unknown (UNK)
Not applicable (NA)
Not available (NAVU)
Other (OTH)
Based on your response, this completes the survey.
To save your responses and end the survey, click the 'End Survey' button below. If you have selected the wrong option by accident and/or wish to return to the survey, click the 'Return and Edit Response' button.